(Q24805892)

2

0 references

Andreas Kirschbaum

3

0 references

Monika McClellan

4

0 references

Thomas Mürdter

5

0 references

Peter Fritz

6

0 references

Godehard Friedel

7

0 references

Michael Thomas

8

0 references

Petra Högger

The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption

9

0 references

language of work or name

English

0 references

publication date

2005

0 references

published in

Respiratory Research

0 references

volume

6

0 references

issue

1

0 references

page(s)

21

0 references

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Potential adverse effects of the inhaled corticosteroids

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Dose response and therapeutic index of inhaled corticosteroids in asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Miniaturized nebulization catheters: a new approach for delivery of defined aerosol doses to the rat lung

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Evaluation of pulmonary absorption using pharmacokinetic methods

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Metabolism kinetics of beclomethasone propionate esters in human lung homogenates

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Pharmacokinetic differences between chlorofluorocarbon and chlorofluorocarbon-free metered dose inhalers of beclomethasone dipropionate in adult asthmatics.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Direct measurement of BDP and 17-BMP in bronchial and peripheral lung tissue after inhalation of HFA- vs CFC-driven aerosols

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-21

Modulite technology: pharmacodynamic and pharmacokinetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-21

Bronchoscopic lung volume reduction using tissue engineering principles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-21

A novel method for assessing dissolution of aerosol inhaler products

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-21

Pharmacokinetics of beclomethasone 17-monopropionate from a beclomethasone dipropionate extrafine aerosol in adults with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-21

Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-21

The relationship between moisture or mould observations in houses and the state of health of their occupants

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-21

Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-21

Comparison of the tissue affinity of glucocorticoids to human lung, nasal and skin tissue in vitro

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=555845

Relationship between lung tissue and blood plasma concentrations of inhaled budesonide

28 November 2018

1 reference

12 December 2020

The ex-vivo isolated, perfused human lung model: description and potential applications

1 reference

12 December 2020

Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site

1 reference

12 December 2020

Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo

1 reference

12 December 2020

Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue

1 reference

12 December 2020

Establishing a therapeutic index for the inhaled corticosteroids: part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids

1 reference

12 December 2020

Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics

1 reference

12 December 2020

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

1 reference

12 December 2020

Drug solubilization in lung surfactant

1 reference

12 December 2020

Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidase

1 reference

12 December 2020

Use of peak flow variability and methacholine responsiveness in predicting changes from pre-test diagnosis of asthma

1 reference

https://api.crossref.org/works/10.1186%2F1465-9921-6-21

7 January 2021